CDH1 and invasive ductal breast carcinoma: While immunohistochemical studies have demonstrated that reduced or absent E-cadherin expression is also common in infiltrating ductal carcinomas (IDCs) [18,19], in the majority of these cases, CDH1 mutations were rare or absent.